Ha ha, 150... Biotech Price per Revenue per Share (P/S) is 6.01 average as of Jan 2013.

6.01 = pps/(Revenue/Outstanding shares), or pps= 6.01*Revenue/Outstanding shares

pps=6.01*$20B/150M= $801.33

Now that is far in the future if Cellceutix were to get all the way through studies and then take market share, and develope to $20 Billion in Revenue... it could happen...